Tang Capital Management Llc - Mar 31, 2025 SCHEDULE 13G/A Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)

Filing Manager
TANG CAPITAL MANAGEMENT LLC
Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Security
CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
CTMX
Shares outstanding
80M shares
Disclosed Ownership
6.72M shares
Ownership
8.4%
Form type
SCHEDULE 13G/A
Date filed
5/15/2025, 04:15 PM
Date of event
Mar 31, 2025
Next filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 8.4% 6.72M 0 6.72M /s/ Kevin Tang Manager
KEVIN TANG 8.4% 6.72M 0 6.72M /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 6.2% 4.96M 0 4.96M /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 2.2% 1.75M 0 1.75M /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer